News About: Pharm. Industry
Win-win strategy of noticeable domestic-multinational companies’ co-marketing
This year, again, domestic pharmaceutical companies have been attracted to co-marketing of multinational pharmaceutical companies’ products. Although a part of the industry has still criticized the phenomenon as ‘subo...
Pharmaceutical industry’s personnel demands increases 2.5% up to 160 thousand by 2024
The pharmaceutical industry’s demands for human resources were expected to increase 2.5% up annually to 160 thousand in 2024.
The Korea Health Industry Development Institute unveiled an observation of the pharmaceut...
While Belviq leads, generic Xenical outnumbers the original
The impact of ‘Belviq’ was significant in the obesity treatment market. Ildong Pharmaceuticals’ Belviq(lorcaserin), which was first launched on March last year, recorded approximately KRW 14 billion sales in 10 months...
Domestic pharmaceutical companies’ clinical trial approvals increases by 11%
According to the analysis result of the 2015’s clinical test approvals of the Ministry of Food and Drug Safety(Minister Seung-hee Kim), there were the total 675 approval cases increased by 3.5% compared to the year of...
Last year’s imported pharmaceutical products of USD 5.1 billion
It encountered a minus growth caused by the last year’s decreased pharmaceutical sales. The phenomenon was shown to occur in reflection of the growth of domestic pharmaceutical products and original products’ patent e...
KPMA’s ‘Chairperson Heng-myung Lee & President Kyung-ho Lee’ system launches
The Korea Pharmaceutical Manufacturers Association(KPMA) was launched in the ‘Chairperson Heng-myung Lee & President Kyung-ho Lee’ system.
The pharmaceutical association held a regular general meeting and a board of ...
Let’s even make it 30 days earlier for ezetimibe generics
Although a hyperlipidemia treatment substance, ‘ezetimibe,’ is about to be expired in patent, a series of domestic companies have filed trials to avoid the patent. The phenomenon is interpreted as their will to launch...
“Samsung Electronics will not dispose Samsung Medison”
On the 24th, CEO Dong-soo Jeon(Medical Device Department Director) of Samsung Electronics officially announced through the Samsung Electronics’ news room page that some of the press reported Samsung Electronics is con...
Prosecution aims for foreign companies, creating impacts on pharmaceutical industry
As searching and seizing Novartis Korea on suspicion of rebates, the prosecution has attracted attention of the pharmaceutical industry.
The focus is whether it will search multinational pharmaceutical companies over...
Is the new drug price privilege only tin god?
While prices of the globally-expanded new drugs have been outlined, the industry complained this year’s policy is only tin god.
It judges the policy contains tight conditions yet low benefits; in the worst cases, som...
